RA-SURE - art photonics

Latest News

22 March 2023

Insights from our CEO: Interview with Laser Focus World

By Stanislav Perevoschikov

Are you curious about the revolutionary ways in which our custom fiber solutions are helping surgeons fight cancer and scientists discover new exoplanets? Our CEO, Viacheslav Artyushenko, shares insights into the limitless potential of our cutting-edge PIR- & CIR-fiber products in his latest interview. Join the likes of the European Space Agency and oncology surgeons […]

16 March 2023

Revolutionize Cancer Diagnosis with Quantum Entangled Photons

By Stanislav Perevoschikov

art photonics is proud to be a part of the Quantum-Enhanced Early Diagnostics (QEED) project, which aims to revolutionize cancer diagnosis and treatment by developing a novel imaging technique based on quantum entangled photon pairs. This technology, known as QEED microscopy, will enable label-free examination of tissue samples in just two minutes, significantly reducing measurement […]

Latest Events

17 March 2023

CPAC Rome | 20-22 March, 2023

By Stanislav Perevoschikov

We are thrilled to announce that Dr. Viacheslav Artyushenko, President of art photonics GmbH, will be presenting at the upcoming CPAC Workshop in Rome on March 20th. Dr. Artyushenko's presentation, titled "Fiber Spectroscopy Solutions for Remote Process-Control in-line", will focus on the application of fiber optic technology in process analytical technology (PAT) for remote process […]

21 February 2023

Meet us at ISLOP 2023

By Stanislav Perevoschikov

Join the top researchers, scientists, and scholars in Lasers, Optics & Photonics at ISLOP2023, a three-day conference for exchanging ideas, presenting sophisticated research, and discussing hot topics in the field. Meet and network with like-minded professionals and gain valuable insights from industry leaders, including Viacheslav Artyushenko, CEO of art photonics GmbH, who will be the […]

Ra-Sure: Raman spectroscopy guided tumour surgery

Oral cavity cancer is a major public health issue, with annually 300.000 new cases and a 50% 5-year survival. Surgery is the mainstay of treatment, but adequate tumour removal is not achieved in 85% of the cases. This affects survival and leads to additional treatment of patients by radiotherapy or chemotherapy. The hands and eyes of the surgeon are insufficient for tumour delineation in the oral cavity. Significant improvement is needed to improve the surgical success rate.

In frames of Ra-Sure, a fully automated Raman spectroscopic device is under development to achieve complete tumour removal in oral cancer surgeries. The product will consist of a dedicated Raman-based tissue inspection device, the operational system and disposable fibre-optic needle probes

A fully automatic inspection device (Ra-Sure) that can perform differentiation between cancer and healthy oral tissues will be developed to the point where it can enter clinical trials. At the end of the project the device will enable rapid (within 15 minutes) inspection of surgically removed tissue in the operating room. As such, surgical removal will be effective in 50% instead of current 15% of the cases. The direct customers of the product will be surgeons and pathologists. As part of the go-to-market strategy, key opinion leaders in oral cancer will be addressed first.

The role of art photonics is the development of the unique Raman fibre-optic needle that can be inserted into the tissue multiple times and measure without loss of quality of the results.

Project Partners

Project Funders